...
机译:组蛋白脱甲基酶KDM7A对治疗前列腺癌的雄激素受体活性和肿瘤生长
Department of UrologySeoul National University HospitalSeoul Republic of Korea;
Department of UrologySeoul National University HospitalSeoul Republic of Korea;
Department of Urology Samsung Medical CenterSungkyunkwan University School of MedicineSeoul;
Department of UrologySeoul National University HospitalSeoul Republic of Korea;
Department of UrologySeoul National University HospitalSeoul Republic of Korea;
Department of UrologySeoul National University HospitalSeoul Republic of Korea;
Department of UrologySeoul National University HospitalSeoul Republic of Korea;
androgen receptor; histone methylation; KDM7A; prostate cancer; Enzalutamide;
机译:组蛋白脱甲基酶KDM7A对治疗前列腺癌的雄激素受体活性和肿瘤生长
机译:Terminal终Terminal的抗组蛋白乙酰转移酶活性对雄激素受体依赖性前列腺癌细胞生长的抑制作用。水果甲醇提取物
机译:EGCG通过抗组蛋白乙酰转移酶活性抑制前列腺癌细胞的生长并调节雄激素受体的乙酰化
机译:红茶多酚茶黄素通过抑制雄激素受体和5α-还原酶的活性抑制LNCaP前列腺癌细胞的生长
机译:重编程雄激素受体和赖氨酸特异性脱甲基酶1转录组在去势抵抗性前列腺癌中
机译:组蛋白脱甲基酶KDM7A调节雄激素受体活性其化学抑制剂TC-E 5002克服了膀胱癌细胞中的顺铂抗性
机译:雄激素受体辅激活因子赖氨酸特异性组蛋白去甲基化酶1和四个半LIm结构域蛋白2预测前列腺癌复发的风险